Barriers to clinical trial participation in multiple myeloma & how to improve these

Barriers to clinical trial participation in multiple myeloma & how to improve theseПодробнее

Barriers to clinical trial participation in multiple myeloma & how to improve these

Understanding Distinct Barriers to Myeloma Clinical Trial ParticipationПодробнее

Understanding Distinct Barriers to Myeloma Clinical Trial Participation

MPE Webinar | Access Barriers to Clinical Trials in CEE CountriesПодробнее

MPE Webinar | Access Barriers to Clinical Trials in CEE Countries

Immune Checkpoint Inhibition in Myeloid MalignanciesПодробнее

Immune Checkpoint Inhibition in Myeloid Malignancies

Prof. David Barnett - To QC or Not to QC - A Reflection on a Career in EQAПодробнее

Prof. David Barnett - To QC or Not to QC - A Reflection on a Career in EQA

2/10/17: Multiple Myeloma: The Good, the Bad and the UglyПодробнее

2/10/17: Multiple Myeloma: The Good, the Bad and the Ugly

Актуальное